These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3601317)

  • 1. Malignant melanoma of the skin. Changing clinical stage at presentation, 1955-1979.
    Hove LM; Akslen LA; Hartveit F
    Oncology; 1987; 44(3):156-8. PubMed ID: 3601317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma: microstages and individualized therapy.
    Tonak J; Hermanek P; Groitl H
    Aust N Z J Surg; 1978 Jun; 48(3):282-6. PubMed ID: 281219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological prognostic criteria in skin melanoma].
    Parshikova SM; Khasanov ShR
    Vopr Onkol; 1991; 37(3):283-8. PubMed ID: 2031322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
    Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
    J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
    van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
    Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2017 complete overhaul of adjuvant therapies for high-risk melanoma and its consequences for staging and management of melanoma patients.
    Eggermont AMM; Dummer R
    Eur J Cancer; 2017 Nov; 86():101-105. PubMed ID: 28968566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based staging system for malignant melanoma: is new necessarily better?
    Baron JM; Abuzahra F
    Lancet; 2004 Jul 31-Aug 6; 364(9432):395-6. PubMed ID: 15288720
    [No Abstract]   [Full Text] [Related]  

  • 13. Elective lymph node dissection in stage I melanoma--necessary or not?
    Adams CM; Giltman LI
    Am Surg; 1985 Sep; 51(9):504-7. PubMed ID: 3898948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of malignant melanoma of the skin with special reference to the vertical tumor diameter].
    Waclawiczek HW; Umlauft M; Weitgasser R
    Chirurg; 1984 Aug; 55(8):508-11. PubMed ID: 6488996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of clinical stage I melanoma patients with positive elective regional node dissection.
    Koh HK; Sober AJ; Day CL; Lew RA; Kopf AW; Lamar W; Ben Cosimi A; Wood WC; Mihm MC; Malt RA
    J Clin Oncol; 1986 Aug; 4(8):1238-44. PubMed ID: 3734848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The adjuvant therapy of malignant melanoma].
    Hauschild A; Sterry W
    Dtsch Med Wochenschr; 1992 Feb; 117(8):303-6. PubMed ID: 1537268
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant chemotherapy in the combined treatment of primary circumscribed malignant melanoma of the skin].
    Korovin SI
    Lik Sprava; 1998 May; (3):114-7. PubMed ID: 9695586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant melanoma--compared worldwide].
    Balch CM; Soong SJ; Shaw HM
    Chirurg; 1986 Oct; 57(10):601-5. PubMed ID: 3491743
    [No Abstract]   [Full Text] [Related]  

  • 19. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between the degree of histological progression (according to Clark and Breslow) and prognosis in cases of malignant melanoma stage I (T1-3, No, Mo)].
    Kwiatkowska W; Dabska M
    Nowotwory; 1983; 33(2):149-52. PubMed ID: 6664885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.